Medication info

Eltoget 10/20 mg tablet

Prescription medicationTabletExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletAtorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Erisun Pharmaceuticals Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP packaging (Alu-Alu) x3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 202101639 · Approved 2021.02.18

This product's status changed to Expired on 2026.02.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who uses it
Adults
Adult dosage
This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Ingredients

Manufacturer
Erisun Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps in reducing elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol, and increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia, or in cases where existing treatment is insufficient. This medication should be used in conjunction with dietary modification during dyslipidemia treatment, and it is important to identify and manage secondary causes such as diabetes and hypothyroidism before treatment. Additionally, during the treatment process, regular checks of total cholesterol, LDL, HDL, and triglyceride levels are conducted for proper management. This treatment contributes to reducing the risk of atherosclerotic vascular diseases due to hypercholesterolemia. Therefore, this medication is effectively used for the treatment of dyslipidemia.

Dosage and Administration

Adult dosage

This medicine is administered once daily, with or without food. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.

Precautions

This medication may cause a rare side effect known as rhabdomyolysis, which can lead to muscle damage. If severe muscle pain or weakness occurs, consult a physician immediately. Caution is necessary for patients with kidney disease or risk factors, as kidney function may deteriorate due to muscle damage. This medication should not be administered to patients with allergies to the active or inactive ingredients, active liver disease, muscle disorders, pregnant or breastfeeding women, and patients taking certain antiviral medications. Patients with poor liver function or a high alcohol intake, elderly patients, those with hypothyroidism, decreased kidney function, or a history of muscle problems should use this medication cautiously. While taking this medication, regular liver function tests and muscle-related tests should be performed, and any unusual symptoms should be reported to healthcare professionals immediately. Additionally, this medication may interact with other drugs; hence, inform your doctor or pharmacist if you are taking any medications, especially when combined with certain antibiotics, antiviral drugs, immunosuppressants, and fibrate medications. Pregnant women or women planning to become pregnant should not take this medication, and fertile women should use appropriate contraceptive methods. This medication is not recommended for children as its safety and efficacy have not been established. Symptoms such as dizziness, muscle pain, and fatigue may occur, so caution is needed when driving or operating machinery. In cases of overdose, no specific antidote exists, so treatment should be symptomatic and supportive, monitoring liver function and muscle enzyme tests. Store this medication out of the reach of children and do not transfer it to other containers.

Side effects

  • Muscle pain
  • abdominal pain
  • increased liver enzymes
  • increased ALT
  • increased AST
  • musculoskeletal pain
  • dizziness
  • cough
  • nausea
  • diarrhea
Show 136 more
  • joint pain
  • muscle weakness
  • hyperkalemia
  • bronchitis
  • sinusitis
  • flushing
  • headache
  • fatigue
  • constipation
  • hyperglycemia
  • hypoglycemia
  • loss of appetite
  • dyspepsia
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • sensory disturbance
  • decreased sensation
  • taste disturbance
  • memory loss
  • peripheral neuropathy
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum creatine kinase
  • positive urine leukocytes
  • nightmares
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • cholelithiasis
  • cholecystitis
  • drug-induced liver injury
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • fatigue
  • chest pain
  • chest discomfort
  • edema
  • weakness
  • systemic edema
  • diabetic neuropathy
  • tremor
  • epigastric pain
  • gastritis
  • dry mouth
  • epigastric discomfort
  • gastrointestinal disorder
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • limb pain
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • rash
  • pruritus
  • upper respiratory infection
  • conjunctival congestion
  • renal failure
  • abnormal liver function
  • increased serum creatinine
  • elevated blood pressure
  • increased blood urea
  • increased CPK
  • abnormal liver function tests
  • intracranial aneurysm
  • restless legs syndrome
  • depression
  • bronchiolitis
  • dental abscess
  • vestibular neuritis
  • bradycardia
  • hypotension
  • hernia
  • vitamin D deficiency
  • gastric polyps
  • duodenal polyps
  • duodenitis
  • jaundice
  • erectile dysfunction
  • breast mass
  • skin mass
  • ingrown toenails
  • thyroid adenoma
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • cognitive impairment
  • severe muscle weakness
  • ocular myasthenia
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP packaging (Alu-Alu) x3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.